MedTrace Logo

Effectiveness of Endocuff Vision in Improving ADR

NCT04395352 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15816

Last updated 2020-05-20

No results posted yet for this study

Summary

The goal of distal attachment devices is to enhance an endoscopist's adenoma detection rate (ADR). A device called EndoCuff Vision (ECV) has been introduced that employs a single row of flexible arms to evert colonic folds, thus optimizing mucosal visualization and enhancing ADR. ECV has been shown to be efficacious in improving ADR within the context of randomized trials. However, no 'real-world' studies have been published assessing the effectiveness of ECV in non-trial settings. The primary objective of this study is to assess the effect of ECV use on ADR in a routine screening-related population.

Conditions

  • Colorectal Neoplasms

Interventions

DEVICE

Endocuff Vision (ECV)

Detachable disposable (single-use) device that fits over the distal colonoscope end.

Sponsors & Collaborators

  • University of Calgary

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2019-11-30
Completion
2019-11-30
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04395352 on ClinicalTrials.gov